©The Author(s) 2015.
World J Gastroenterol. Jan 21, 2015; 21(3): 711-725
Published online Jan 21, 2015. doi: 10.3748/wjg.v21.i3.711
Published online Jan 21, 2015. doi: 10.3748/wjg.v21.i3.711
Table 2 Comparison of biological and protein function of ALT1 and ALT2: Background information and recent findings
| Features and function | Glutamic-pyruvate transaminase 1 (alanine aminotransferase 1) GPT1 | Glutamic pyruvate transaminase 2 (alanine aminotransferase) 2 GPT2 |
| Gene and protein Id in data-bases | Entrez gene: 2875 | Entrez gene: 84706 |
| Ensembl gene: ENSG00000167701 | Ensemble: ENSG00000166123 | |
| UniProtKB: P24298 | UniProtKB: Q8TD30 | |
| Genomic location | Entrez gene cytogenetic band: 8q24.3 | Entrez gene cytogenetic band: 16q12.1 |
| Number of gene transcripts | 7 transcripts (splice variants), 28 exons on the forward strand | 5 transcripts (splice variants), 26 exons on the forward strand |
| Variation | GPT1 has 210 SNPs | GPT2 has 819 SNPs |
| Orthologues | GPT1 has 69 orthologues in Ensembl | GPT2 has 63 orthologues in Ensembl |
| Regulation | There are 2 regulatory elements located in the region of GPT1 gene | There are 13 regulatory elements located in the region of GPT2 |
| miR-122 may interact with GPT1 at multiple sites of the coding region to enhance translation[21] | GPT2 promoter has a putative ATF4 (Activating transcription factor 4 binding site[69] | |
| Microsomal triglyceride transfer protein inhibition augments plasma ALT/AST levels in response to endoplasmic reticulum stress[66] | GPT2 is regulated by androgens in non-hepatic tissues[70] | |
| GPT1, but not GPT2 promoter is induced by PPAR agonists[67] | ||
| ALT1 catalytic activity is inhibited by the effect of glycation[68] | ||
| Protein features | Size: 496 amino acids; 54637 Da | Size: 523 amino acids; 57904 Da |
| Cofactor: Pyridoxal phosphate | Cofactor: Pyridoxal phosphate | |
| Subunit: Homodimer | Subunit: Homodimer (By similarity) | |
| Cellular localization in human cells1 | Cytosol of hepatocytes[18] | ER and mitochondrial fraction[18] |
| Measurement in plasma (catalytic activity) | Represents 90% of total ALT in circulation[17,18] | Represents 10% of total ALT in circulation[17,18] |
| Tissue expression in humans | Evidence: WB: Liver and kidney[18] | Evidence: WB and IHQ (protein): Pancreas (islets of Langerhans), brain, adrenal gland, skeletal muscle, heart (cardiomyocytes)[18] |
| Evidence: NB: GPT mRNA is moderately expressed in kidney, liver, heart, and fat[15] | Evidence: NB: mRNA is expressed at high levels in muscle, fat, kidney, and brain, and at lower levels in liver and breast[15] | |
| Tissue expression in rodents | Evidence: NB (mRNA): Highly expressed in liver and moderately expressed in white adipose tissue (WAT), intestine, and colon[71] | Evidence: NB (mRNA): muscle, liver, and white adipose tissue (WAT), at moderate levels in brain and kidney, and at a low level in heart[71] |
| Gene expression analysis suggests a sex-dependent difference in GPT2-mRNA in the liver and muscle[15] | ||
| Hepatic and muscle ALT2 protein activity was higher in males than in females; while no sex-dependent difference was noted in the liver for ALT1, it appears 20% higher in muscle in females[15] | ||
| Biological meaning and metabolic function | ALT1 contributes to “basal” serum ALT activity, most likely associated with normal cell turnover in liver and other tissues that would release ALT1 into the circulation[15,17-19] | Generation of pyruvate for gluconeogenesis under stressful living conditions, such as starvation[18] |
| ALT2 is involved in the metabolic adaptation of the cell to stress[69] | ||
| ALT2 is associated with a liver progluconeogenic metabolic adaptive response without hepatocellular necrosis after exposure to dexamethasone[72] | ||
| ALT2 may participate in the generation of pyruvate and glyceroneogenesis, contributing to the homeostasis of fatty acid metabolism and storage[16] | ||
| Biological meaning in human disease | NAFLD: ALT1 represented 94% of total ALT levels in circulation[19] | NAFLD: ALT2 represented 6% of total ALT levels in circulation[19] |
| HCV: High levels in circulation of ALT1 (about 5-fold increase as compared to the controls)[19] | HCV: Moderate levels in circulation of ALT1 (about 2.5 fold increase as compared to the controls)[19] | |
| Ultra-endurance exercise: no significant changes after exercise[19] | Ultra-endurance exercise: High levels in circulation of ALT2 (about 2-fold increase as compared to the baseline conditions)[19] | |
| Biological meaning in experimental models of disease | NAFLD (ob/ob): Compared to the normal liver of lean mice, the expression of GPT1 mRNA remained unchanged[71] | NAFLD (ob/ob): Compared to the normal liver of lean mice, the expression of GPT2 mRNA was elevated by about 2-fold, suggesting ALT2 induction during fatty liver[71] |
| Both ALT1 and ALT2 increased in the liver of mice induced liver steatosis by a deficient methionine-choline diet[73] |
- Citation: Sookoian S, Pirola CJ. Liver enzymes, metabolomics and genome-wide association studies: From systems biology to the personalized medicine. World J Gastroenterol 2015; 21(3): 711-725
- URL: https://www.wjgnet.com/1007-9327/full/v21/i3/711.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i3.711